List of works by Ignacio Garrido-Laguna

A 30-Year-Old Man with Three Primary Malignancies: A Case of Constitutional Mismatch Repair Deficiency

scientific article published on March 2017

A framework for genomic biomarker actionability and its use in clinical decision making

scientific article

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer

scientific article published on 12 September 2017

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer

scientific article

Case report: pembrolizumab-induced Type 1 diabetes in a patient with metastatic cholangiocarcinoma

scientific article

Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis

scientific article published on 17 October 2017

Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden

scientific article published on 14 August 2018

Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models

scientific article

Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors

scientific article

Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah

scientific article

Genomically Driven Tumors and Actionability across Histologies: BRAF-Mutant Cancers as a Paradigm

scientific article published on 23 March 2016

Is There Any Reason to Delay Introduction of Tumor Necrosis Factor in the Management of In-Transit Metastasis of Unresectable Melanoma?

scientific article published on 01 March 2007

KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors

scientific article

Large database utilization in health outcomes research in pancreatic cancer: an update

article

Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer

scientific article published on 16 June 2017

N of 1 case reports of exceptional responders accrued from pancreatic cancer patients enrolled in first-in-man studies from 2002 through 2012.

scientific article

New scaffolds for the design of selective estrogen receptor modulators

scientific article

Novel therapeutic targets in non-small cell lung cancer

scientific article published on September 2011

Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experience

scientific article published on 25 April 2012

Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic

scientific article published on 21 February 2011

PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations

scientific article published on 23 January 2012

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers

scientific article

PIK3CA mutations in advanced cancers: characteristics and outcomes

scientific article published on December 2012

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

scientific article

Pancreatic cancer: from state-of-the-art treatments to promising novel therapies

scientific article published on 31 March 2015

Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue.

scientific article published on 14 July 2016

Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment

scientific article published on 4 June 2010

Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies

scientific article

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer

scientific article

Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy

scientific article

Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer

scientific article

Response of histiocytoses to imatinib mesylate: fire to ashes

scientific article

Response to nab-paclitaxel plus gemcitabine in a patient with primary resistance to FOLFIRINOX.

scientific article published in December 2014

Ridaforolimus in advanced sarcomas: a leap forward or missed opportunity?

scientific article published on 30 January 2012

Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma

scientific article published on 14 October 2020

TIGIT: a novel immunotherapy target moving from bench to bedside

scientific article published on 19 September 2018

Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome

scientific article published on February 2015

Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome

scientific article published on December 2014

Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome.

scientific article published on December 2014

The inverted pyramid of biomarker-driven trials.

scientific article published on 2 August 2011

Upper gastrointestinal malignancies in 2017: current perspectives and future approaches.

scientific article published on 15 March 2018

Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center

scientific article published on 5 August 2011

Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins.

scientific article

Paulina is supported by:

About Paulina

Help